EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 182 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2019. The put-call ratio across all filers is 2.65 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,768 | -18.9% | 556 | 0.0% | 0.00% | -100.0% |
| Q2 2023 | $10,809 | -31.5% | 556 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $15,774 | -29.2% | 556 | -27.0% | 0.00% | 0.0% |
| Q4 2022 | $22,273 | +10.6% | 762 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $20,132 | -40.5% | 762 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $33,856 | -10.2% | 762 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $37,711 | -79.1% | 762 | -78.5% | 0.00% | -50.0% |
| Q4 2021 | $180,206 | -8.7% | 3,539 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $197,405 | +30.3% | 3,539 | 0.0% | 0.00% | +50.0% |
| Q2 2021 | $151,469 | +2.5% | 3,539 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $147,718 | -10.4% | 3,539 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $164,811 | +9.6% | 3,539 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $150,337 | -11.5% | 3,539 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $169,801 | +5.1% | 3,539 | +0.7% | 0.00% | 0.0% |
| Q1 2020 | $161,598 | -23.4% | 3,513 | 0.0% | 0.00% | -25.0% |
| Q4 2019 | $211,061 | +6.2% | 3,513 | 0.0% | 0.00% | +33.3% |
| Q3 2019 | $198,730 | +1.6% | 3,513 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $195,604 | +10.3% | 3,513 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $177,371 | +25.3% | 3,513 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $141,539 | -41.9% | 3,513 | 0.0% | 0.00% | -25.0% |
| Q3 2018 | $243,556 | -99.9% | 3,513 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $265,794,000 | +75.7% | 3,513 | +22.4% | 0.00% | +100.0% |
| Q1 2018 | $151,273,000 | +108729.5% | 2,871 | +10.2% | 0.00% | 0.0% |
| Q4 2017 | $139,000 | -58.6% | 2,606 | -53.7% | 0.00% | 0.0% |
| Q3 2017 | $336,000 | -27.6% | 5,630 | -4.3% | 0.00% | -33.3% |
| Q2 2017 | $464,000 | -10.3% | 5,882 | -5.7% | 0.00% | -25.0% |
| Q1 2017 | $517,000 | +4.4% | 6,236 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $495,000 | +13.3% | 6,236 | 0.0% | 0.00% | +33.3% |
| Q3 2016 | $437,000 | +80.6% | 6,236 | 0.0% | 0.00% | +50.0% |
| Q2 2016 | $242,000 | -4.3% | 6,236 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $253,000 | -54.2% | 6,236 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $553,000 | +19.7% | 6,236 | 0.0% | 0.00% | +33.3% |
| Q3 2015 | $462,000 | -8.7% | 6,236 | -0.3% | 0.00% | -25.0% |
| Q2 2015 | $506,000 | – | 6,254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |